Global Human Rabies Immunoglobulin (IM) Market Growth 2023-2029

Global Human Rabies Immunoglobulin (IM) Market Growth 2023-2029

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.

In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)

LPI (LP Information)' newest research report, the “Human Rabies Immunoglobulin (IM) Industry Forecast” looks at past sales and reviews total world Human Rabies Immunoglobulin (IM) sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Rabies Immunoglobulin (IM) sales for 2023 through 2029. With Human Rabies Immunoglobulin (IM) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Rabies Immunoglobulin (IM) industry.

This Insight Report provides a comprehensive analysis of the global Human Rabies Immunoglobulin (IM) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Rabies Immunoglobulin (IM) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Human Rabies Immunoglobulin (IM) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Rabies Immunoglobulin (IM) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Rabies Immunoglobulin (IM).

The global Human Rabies Immunoglobulin (IM) market size is projected to grow from US$ 387.4 million in 2022 to US$ 599.3 million in 2029; it is expected to grow at a CAGR of 599.3 from 2023 to 2029.

Global Human Rabies Immunoglobulin (IM) key players include CSL Behring, Grifols, Sanofi, etc. Global top three manufacturers hold a share about 60%.

North America is the largest market, with a share over 30%, followed by China and Europe, both have a share about 45 percent.

In terms of product, HRIG is the largest segment, with a share over 85%. And in terms of application, the largest application is Category III Exposure, followed by Category II Exposure.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Rabies Immunoglobulin (IM) market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

ERIG

HRIG

Segmentation by application

Category II Exposure

Category III Exposure

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

CSL Behring

Grifols

Sanofi

Sichuan Yuanda Shuyang

CNBG

Kamada

CBPO

Shuanglin Bio

Weiguang Bio

Shanghai RAAS

Bharat Serum

VINS

Key Questions Addressed in this Report

What is the 10-year outlook for the global Human Rabies Immunoglobulin (IM) market?

What factors are driving Human Rabies Immunoglobulin (IM) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Human Rabies Immunoglobulin (IM) market opportunities vary by end market size?

How does Human Rabies Immunoglobulin (IM) break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.